Status:
COMPLETED
BiPAP for Cardiomyopathy With Central Sleep Apnea
Lead Sponsor:
Nagoya University
Conditions:
Dilated Cardiomyopathy
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.
Eligibility Criteria
Inclusion
- Idiopathic dilated cardiomyopathy
Exclusion
- a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00282789
Start Date
June 1 2000
Last Update
January 30 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya University of Health Sciences
Nagoya, Japan, 461-8673